Large research studies confirm that diabetes increases the prevalence and incidence of urinary incontinence and OAB in both type 1 and type 2 diabetes in both men and women, Risk factors include being older, how long you have been a diabetic, and whether you have good control of your blood sugar. Studies highlight reasons for diabetic bladder dysfunction are multifactorial, involving changes in detrusor bladder muscle, urothelium (the estrogen sensitive lining tissue), nerve aging, and vascular supply, with oxidative stress and inflammation playing a role. Stress urinary incontinence (leaking with coughing and sneezing) is also more common in women with diabetes.
weight loss interventions have benefit incontinence in prediabetic and diabetic women
Regarding GLP-1 receptor agonists, the science consists of animal studies, with insufficient clinical data to draw conclusions about their direct effects on bladder function in humans. Most studies of antidiabetic medications and bladder function have focused on insulin and classic oral agents such as Metformin, with GLP-1 RAs not yet studied.
Emsella Bladder Treatment is approved for incontinence therapy. It is non-invasive and painless. We’d like to discuss your options.
